Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Colorectal Phase 2 Trials

Madison, Wisconsin

Phase 2 colorectal cancer trials in Madison, WI

7 Phase 2 colorectal cancer studies are recruiting participants at sites in Madison as of November 18, 2026, according to ClinicalTrials.gov. Colorectal Phase 2 Trials can help you understand your options and connect with a study team.

Call (888) 467-9061
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Madison at a glance

  • 7 studies are recruiting at a site in Madison.
  • By phase: Phase 2 (7).
  • By sponsor: industry (3), university, hospital or other (3), government (1).
  • Most recent update to one of these records: November 18, 2026.

Studies recruiting in Madison

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. TPST-1495 in Patients With Familial Adenomatous Polyposis

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    University of Wisconsin Carbone Cancer Center - University Hospital
    Registry record
    NCT06557733 · updated
  2. A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Verastem, Inc.
    Study site
    University of Wisconsin
    Registry record
    NCT07659795 · updated
  3. Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Dustin Deming
    Study site
    University of Wisconsin
    Registry record
    NCT06493019 · updated
  4. Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

    • Phase 2
    • Ages 18 to 130
    • All sexes
    Sponsor
    AstraZeneca
    Registry record
    NCT05489211 · updated
  5. Liposomal Irinotecan With TAS102 and Bevacizumab for Patients With Metastatic Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    University of Wisconsin, Madison
    Study site
    University of Wisconsin Carbone Cancer Center
    Registry record
    NCT05854498 · updated
  6. Single Arm Study of Neoadjuvant Dostarlimab in Stage II and III Deficient Mismatch Repair Colon Cancers

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    University of Iowa
    Study site
    University of Wisconsin
    Registry record
    NCT05239546 · updated
  7. APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Apollomics Inc.
    Study site
    University of Wisconsin
    Registry record
    NCT03175224 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Madison, WI on ClinicalTrials.gov.

Ask about studies near Madison

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 2, as each study is coded in the registry.

Colorectal Phase 2 Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 467-9061

or send a short form

How should we reach you?

Call